Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOPROSTENOL vs TREPROSTINIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPOPROSTENOL vs TREPROSTINIL: Safety Overview

Metric EPOPROSTENOL TREPROSTINIL
Total FAERS Reports 13,322 91,795
Deaths Reported 2,713 8,865
Death Rate 20.4% 9.7%
Hospitalizations 8,838 35,507
Average Patient Age 49.9 yrs 58.6 yrs
% Female Patients 78.1% 73.2%
FDA Approval Date Apr 23, 2008 Feb 11, 2021
Manufacturer Mylan Institutional LLC United Therapeutics Corporation
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription